CNS
Overvalued by 52.4% based on the discounted cash flow analysis.
Market cap | $3.86 Billion |
---|---|
Enterprise Value | $3.81 Billion |
Dividend Yield | $2.42 (3.19809700013215%) |
Earnings per Share | $3 |
Beta | 1.32 |
Outstanding Shares | 51,058,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 24.6 |
---|---|
PEG | 144.89 |
Price to Sales | 7.49 |
Price to Book Ratio | 6.24 |
Enterprise Value to Revenue | 6.84 |
Enterprise Value to EBIT | 18.72 |
Enterprise Value to Net Income | 24 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.03 |
No data
No data